Risk Prediction of Cardiovascular Complications in Pregnant Women With Heart Disease
- PMID: 26959402
- PMCID: PMC4845701
- DOI: 10.5935/abc.20160028
Risk Prediction of Cardiovascular Complications in Pregnant Women With Heart Disease
Abstract
Background: Heart disease in pregnancy is the leading cause of non- obstetric maternal death. Few Brazilian studies have assessed the impact of heart disease during pregnancy.
Objective: To determine the risk factors associated with cardiovascular and neonatal complications.
Methods: We evaluated 132 pregnant women with heart disease at a High-Risk Pregnancy outpatient clinic, from January 2005 to July 2010. Variables that could influence the maternal-fetal outcome were selected: age, parity, smoking, etiology and severity of the disease, previous cardiac complications, cyanosis, New York Heart Association (NYHA) functional class > II, left ventricular dysfunction/obstruction, arrhythmia, drug treatment change, time of prenatal care beginning and number of prenatal visits. The maternal-fetal risk index, Cardiac Disease in Pregnancy (CARPREG), was retrospectively calculated at the beginning of prenatal care, and patients were stratified in its three risk categories.
Results: Rheumatic heart disease was the most prevalent (62.12%). The most frequent complications were heart failure (11.36%) and arrhythmias (6.82%). Factors associated with cardiovascular complications on multivariate analysis were: drug treatment change (p = 0.009), previous cardiac complications (p = 0.013) and NYHA class III on the first prenatal visit (p = 0.041). The cardiovascular complication rates were 15.22% in CARPREG 0, 16.42% in CARPREG 1, and 42.11% in CARPREG > 1, differing from those estimated by the original index: 5%, 27% and 75%, respectively. This sample had 26.36% of prematurity.
Conclusion: The cardiovascular complication risk factors in this population were drug treatment change, previous cardiac complications and NYHA class III at the beginning of prenatal care. The CARPREG index used in this sample composed mainly of patients with rheumatic heart disease overestimated the number of events in pregnant women classified as CARPREG 1 and > 1, and underestimated it in low-risk patients (CARPREG 0).
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Predictors for complications in pregnant women with heart disease, a retrospective study.J Med Assoc Thai. 2014 Jul;97(7):730-5. J Med Assoc Thai. 2014. PMID: 25265772
-
Cardiac Complications during Pregnancy Related to Parity in Women with Congenital Heart Disease.Cardiology. 2020;145(8):533-542. doi: 10.1159/000508649. Epub 2020 Jul 13. Cardiology. 2020. PMID: 32659772 Free PMC article.
-
Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center.Int J Cardiol. 2011 Sep 1;151(2):209-13. doi: 10.1016/j.ijcard.2010.05.045. Epub 2010 Jul 24. Int J Cardiol. 2011. PMID: 20659773
-
Pregnancy and cardiac maternal outcomes in women with inherited cardiomyopathy: interest of the CARPREG II risk score.ESC Heart Fail. 2024 Jun;11(3):1506-1514. doi: 10.1002/ehf2.14694. Epub 2024 Feb 15. ESC Heart Fail. 2024. PMID: 38361389 Free PMC article.
-
Assessing Cardiac Risk in Pregnant Women With Heart Disease: How Risk Scores Are Created and Their Role in Clinical Practice.Can J Cardiol. 2020 Jul;36(7):1011-1021. doi: 10.1016/j.cjca.2020.02.079. Epub 2020 Feb 24. Can J Cardiol. 2020. PMID: 32502425 Review.
Cited by
-
Reply to Letter to the Editor titled: A well validated risk stratification index predicts poor maternal and fetal outcomes.Indian Heart J. 2021 Jul-Aug;73(4):528-529. doi: 10.1016/j.ihj.2021.06.001. Epub 2021 Jun 12. Indian Heart J. 2021. PMID: 34474776 Free PMC article. No abstract available.
-
Validation of modified World Health Organization classification for pregnant women with heart disease in a tertiary care center in southern Thailand.Int J Womens Health. 2018 Jan 18;10:47-53. doi: 10.2147/IJWH.S150767. eCollection 2018. Int J Womens Health. 2018. PMID: 29403316 Free PMC article.
-
The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease.Cardiovasc J Afr. 2018 Nov/Dec 23;29(6):394-403. doi: 10.5830/CVJA-2018-044. Epub 2018 Sep 18. Cardiovasc J Afr. 2018. PMID: 30234226 Free PMC article. Review.
-
Position Statement on Exercise During Pregnancy and the Post-Partum Period - 2021.Arq Bras Cardiol. 2021 Jul;117(1):160-180. doi: 10.36660/abc.20210408. Arq Bras Cardiol. 2021. PMID: 34320089 Free PMC article. English, Portuguese. No abstract available.
-
Predictors of maternal and neonatal complications in women with severe valvular heart disease during pregnancy in Tunisia: a retrospective cohort study.BMC Pregnancy Childbirth. 2021 Dec 8;21(1):813. doi: 10.1186/s12884-021-04259-6. BMC Pregnancy Childbirth. 2021. PMID: 34876044 Free PMC article.
References
-
- Ministério da Saúde . Indicadores de dados. Datasus; Brasilia: 2009. [2015 Jul 10]. Disponível em: http://tabnet.datasus.gov.br/cgi/idb2009/C03b.htm.
-
- Sociedade Brasileira de Cardiologia Guidelines for pregnancy in the woman with heart disease. Arq Bras Cardiol. 2009;93(6) supl.1:e110–e78. - PubMed
-
- Confidential Enquiry into Maternal and Child Health Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer. 2003-2005. 7 Report of the Confidential Enquires into Maternal Deaths in the UK. Obstet Med. 2008;1(1):54–54.
-
- Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Cardiac Disease in Pregnancy Investigators Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–521. - PubMed
-
- Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, ZAHARA Investigators et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31(17):2124–2132. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical